← Back to Search

Device

Spinal cord stimulation for Parkinson's Disease

N/A
Waitlist Available
Led By Mandar Jog, MD
Research Sponsored by Western University, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights

Study Summary

This trial is testing a new way to treat Parkinson's and atypical Parkinsonism by zapping the spine with electrical stimulation. They want to figure out what settings work best.

Eligible Conditions
  • Parkinson's Disease
  • Parkinsonism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in spatiotemporal gait measures using objective gait analysis
Tailored SCS programming
Secondary outcome measures
Changes in ABC scores
Changes in NFOG-Q scores
Changes in PDQ-39 scores
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Spinal cord stimulationExperimental Treatment1 Intervention
Boston Scientific SCS system
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spinal cord stimulation
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor
239 Previous Clinical Trials
57,468 Total Patients Enrolled
Mandar Jog, MDPrincipal InvestigatorLHSC
7 Previous Clinical Trials
459 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
NeuronJournal
Spinal Cord Stimulation Alleviates Motor Deficits in a Primate Model of Parkinson Disease
Santana, Maxwell B., Pär Halje, Hougelle Simplício, Ulrike Richter, Marco Aurelio M. Freire, Per Petersson, Romulo Fuentes, and Miguel A.L. Nicolelis. 2014. “Spinal Cord Stimulation Alleviates Motor Deficits in a Primate Model of Parkinson Disease”. Neuron. Elsevier BV. doi:10.1016/j.neuron.2014.08.061.
Journal of Clinical NeuroscienceJournal
A Patient with Parkinson’s Disease Benefits from Spinal Cord Stimulation
Hassan, Syed, Syed Amer, AbdulRehman Alwaki, and Ahmed Elborno. 2013. “A Patient with Parkinson’s Disease Benefits from Spinal Cord Stimulation”. Journal of Clinical Neuroscience. Elsevier BV. doi:10.1016/j.jocn.2012.08.018.
BrainJournal
Effects of Pedunculopontine Nucleus Area Stimulation on Gait Disorders in Parkinson's Disease
Ferraye, M. U., B. Debu, V. Fraix, L. Goetz, C. Ardouin, J. Yelnik, C. Henry-Lagrange, et al.. 2009. “Effects of Pedunculopontine Nucleus Area Stimulation on Gait Disorders in Parkinson's Disease”. Brain. Oxford University Press (OUP). doi:10.1093/brain/awp229.
ScienceJournal
Spinal Cord Stimulation Restores Locomotion in Animal Models of Parkinson's Disease
Fuentes, Romulo, Per Petersson, William B. Siesser, Marc G. Caron, and Miguel A. L. Nicolelis. 2009. “Spinal Cord Stimulation Restores Locomotion in Animal Models of Parkinson's Disease”. Science. American Association for the Advancement of Science (AAAS). doi:10.1126/science.1164901.
All > Parkinson > Spinal Cord
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top